North America Health News
FDA approvals, recalls, guidance and public health reports from the United States and Canada.
Stories by edition
Week ending 25 October 2026
Only 3 stories met the bar this week.
- FDA grants accelerated approval to ravulizumab for proteinuria in primary IgA nephropathy (761108Orig1s046ltr.pdf)
- CDC and FDA investigate multistate Salmonella outbreak linked to Virginia oysters (19 October 2026)
- NIH reports early results for invikafusp alfa in treatment resistant solid tumours (23 October 2026)
Week ending 18 October 2026
Only 4 stories met the bar this week.
- FDA finalises guidance on manufacturing changes to biosimilars (13 October 2026)
- FDA expands bladder cancer treatment to papillary-only disease (14 October 2026)
- FDA approves first nonprescription apraclonidine eye drop for redness (16 October 2026)
- FDA approves eye drop for presbyopia in adults (16 October 2026)
Week ending 11 October 2026
Only 3 stories met the bar this week
- FDA approves Hovilpri for herpes simplex lesions that do not respond to standard antivirals (9 October 2026)
- Two lots of anaesthetic Brevital Sodium recalled over particulate matter (9 October 2026)
- Frequent mental distress among young US adults remains far above 2012 levels, CDC finds (8 October 2026)
Week ending 4 October 2026
Only 1 story met the bar this week